Preliminary research reveal conolidine may inhibit particular ion channels, cutting down neuronal excitability and limiting discomfort indicators. This system is especially pertinent in neuropathic agony, wherever irregular signaling causes persistent distress. Moreover, conolidine appears to influence G protein-coupled receptor (GPCR) pathways int